-
Mashup Score: 0
Read how immune cells contribute to lung injury and regeneration, and how novel technologies may delineate immune cell–epithelium cross-talk in COPD and expedite precision pro-regenerative approaches toward reprogramming the alveolar immune niche https://bit.ly/46IhKFK
Source: erj.ersjournals.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 8KFF Survey of Consumer Experiences with Health Insurance | KFF - 7 month(s) ago
The survey finds nearly six in 10 people with health insurance experienced a problem using their insurance in the past year, with even larger shares reporting problems among people who are sick or who have mental health needs. It includes data for people with different types of coverage, including employer, Marketplace, Medicare and Medicaid, and also examines affordability issues and mental health access.
Source: www.kff.orgCategories: Latest Headlines, PulmonologyTweet-
17% of insured adults report that, even with health coverage, they did not get mental health care they thought they needed in the past year. About a third of that group said their insurance not covering the services was a reason they did not get the care. https://t.co/9mU4kSVHnN https://t.co/ArGSpDyJUF
-
-
Mashup Score: 0
HONOLULU — Treatment with nintedanib plus pirfenidone resulted in a similar frequency of adverse events as monotherapy among patients with idiopathic pulmonary fibrosis, according to a systemic review presented at the CHEST Annual Meeting.However, use of nintedanib (Ofev, Boehringer Ingelheim) and pirfenidone together, both antifibrotic medications with different pharmacodynamics, increased
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
🔑 takeaways from a #CHEST2023 presentation: ➡️ #Nintedanib plus #pirfenidone led to a comparable rate of adverse events as monotherapy in #IPF. ➡️ Combination therapy may lead to less decline in #FVC compared with monotherapy. https://t.co/7maf5Az3Ti
-
-
Mashup Score: 0
HONOLULU — The implementation of a post-acute exacerbation COPD clinic reduced hospital readmissions, according to a poster presented at the CHEST Annual Meeting.“We know there’s a high rate of readmission for COPD patients and that recurrent hospitalization leads to quicker deterioration of lung function and the overall health in these patients,” Mollie Anderson, APRN,
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
🗨️“We know there’s a high rate of readmission for #COPD patients and that recurrent hospitalization leads to quicker deterioration of #lung function and the overall health in these patients,” Mollie Anderson, APRN, FNP, at @VUMChealth, told Healio. https://t.co/kCUtQZLQ1l
-
-
Mashup Score: 2Investigating Associations of Omega-3 Fatty Acids, Lung Function Decline, and Airway Obstruction - 7 month(s) ago
Rationale: Inflammation contributes to lung function decline and the development of chronic obstructive pulmonary disease. Omega-3 fatty acids have antiinflammatory properties and may benefit lung …
Source: www.atsjournals.orgCategories: Latest Headlines, PulmonologyTweet-
The Blue Journal thanks Bonnie Patchen, PhD, RD, for her contribution to the October 15 issue Investigating Associations of Omega-3 Fatty Acids, Lung Function Decline, and Airway Obstruction https://t.co/s66NHmRyak https://t.co/3VxDCA6dBV
-
-
Mashup Score: 1Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation. Mechanistic Implications for Desquamative Interstitial Pneumonitis - 7 month(s) ago
Bleomycin-induced pulmonary fibrosis in mice mimics major hallmarks of idiopathic pulmonary fibrosis. Yet in this model, it spontaneously resolves over time. We studied molecular mechanisms of fibr…
Source: www.atsjournals.orgCategories: Latest Headlines, PulmonologyTweet-
Transcriptomic and Proteomic Changes Driving Pulmonary Fibrosis Resolution in Young and Old Mice 🔗 https://t.co/Nz2VvXhdZj https://t.co/xslQWIxoRO
-
-
Mashup Score: 0Patient Voices 12 - 7 month(s) ago
American Thoracic Society
Source: www.thoracic.orgCategories: Latest Headlines, PulmonologyTweet-
The 12th edition of ATS Patient Voices is here!🗣️ ATS Patient Voices is published by the ATS Public Advisory Roundtable (PAR). Swipe👉through excerpts from John Torrence's struggle with #Bronchiectasis. 📩 Read the full Patient Voices book here: https://t.co/BGEitmLTw5 https://t.co/TlpkxfgPY0
-
-
Mashup Score: 0How Medicare’s New Drug Price Negotiation Program Could Expand Access to Selected Drugs | KFF - 7 month(s) ago
This brief examines how Medicare Part D enrollees’ access to and utilization of the first set of 10 selected drugs could be affected by the new Part D coverage and formulary requirements for selected drugs established by the Inflation Reduction Act and in CMS guidance, as well as the potential for lower out-of-pocket costs.
Source: www.kff.orgCategories: Latest Headlines, PulmonologyTweet-
While Medicare’s new drug price negotiation program is projected to lower Medicare spending, less attention has been given to how it could expand access to, and use of, the drugs selected for negotiation for Part D enrollees. Our new brief explains how: https://t.co/YukbdYy8Qn
-
-
Mashup Score: 0
HONOLULU — Treatment with nintedanib plus pirfenidone resulted in a similar frequency of adverse events as monotherapy among patients with idiopathic pulmonary fibrosis, according to a systemic review presented at the CHEST Annual Meeting.However, use of nintedanib (Ofev, Boehringer Ingelheim) and pirfenidone together, both antifibrotic medications with different pharmacodynamics, increased
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Presented at #CHEST2023: Treatment with #nintedanib plus #pirfenidone 💊 resulted in a similar frequency of adverse events as monotherapy among patients with idiopathic pulmonary fibrosis (#IPF). https://t.co/7maf5Az3Ti
-
-
Mashup Score: 0
HONOLULU — The implementation of a post-acute exacerbation COPD clinic reduced hospital readmissions, according to a poster presented at the CHEST Annual Meeting.“We know there’s a high rate of readmission for COPD patients and that recurrent hospitalization leads to quicker deterioration of lung function and the overall health in these patients,” Mollie Anderson, APRN,
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
At #CHEST2023: The implementation of a post-acute exacerbation #COPD clinic reduced hospital readmissions 🏥. https://t.co/kCUtQZLQ1l
-
ERJ: Read how immune cells contribute to lung injury and regeneration, and how novel technologies may delineate immune cell–epithelium cross-talk in COPD and expedite precision pro-regenerative approaches toward reprogramming the alveolar immune niche https://t.co/IblEv6S9J1 https://t.co/IvngxqybE6